îæ€çŽ¢
îæ€çŽ¢
î
Can Fite Biopharma Ltd
CANFîãŠã©ãããªã¹ãã«è¿œå
3.170USD
-0.110-3.35%
çµå€Â 07-31 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
27.67Kæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
æ ªäž»
æŽæ°æå»: Sat, May 2
æŽæ°æå»: Sat, May 2
æ ªäž»çµ±èš
çš®é¡
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Rhumbline Advisers Ltd. Partnership
0.98%
Citi Investment Research (US)
0.26%
UBS Financial Services, Inc.
0.10%
Abalone Asset Management Ltd.
0.09%
Osaic Holdings, Inc.
0.08%
ä»ã®
98.49%
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Rhumbline Advisers Ltd. Partnership
0.98%
Citi Investment Research (US)
0.26%
UBS Financial Services, Inc.
0.10%
Abalone Asset Management Ltd.
0.09%
Osaic Holdings, Inc.
0.08%
ä»ã®
98.49%
çš®é¡
æ ªäž»çµ±èš
æ¯ç
Investment Advisor
0.94%
Research Firm
0.48%
Venture Capital
0.04%
Hedge Fund
0.03%
ä»ã®
98.50%
æ©é¢æè³å®¶ä¿ææ ª
îæŽæ°æå»: Wed, Apr 1
æŽæ°æå»: Wed, Apr 1
å ±åæé
æ©é¢æè³å®¶æ°
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
2026Q1
28
32.13K
1.50%
-81.64K
2025Q4
30
1.56M
6.39%
--
2025Q3
33
1.56M
9.88%
+633.60K
2025Q2
31
928.79K
6.69%
+773.65K
2025Q1
30
155.14K
8.36%
-710.63K
2024Q4
28
138.24K
8.71%
-639.91K
2024Q3
26
778.14K
10.55%
+126.51K
2024Q2
26
651.74K
10.05%
+134.05K
2024Q1
24
517.69K
5.29%
+253.94K
2023Q4
29
283.94K
2.08%
+216.17K
詳现ãèŠã
æ ªäž»åå
îäŒç€Ÿå
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
å€åç
æ¥ä»
Rhumbline Advisers Ltd. Partnership
14.09K
0.66%
+11.20K
+386.50%
Dec 31, 2025
UBS Financial Services, Inc.
1.05K
0.05%
+982.00
+1510.77%
Dec 31, 2025
Abalone Asset Management Ltd.
2.00K
0.09%
+809.00
+67.93%
Dec 31, 2024
Osaic Holdings, Inc.
1.80K
0.08%
+1.80K
--
Dec 31, 2025
XTX Markets LLC
934.00
0.04%
+934.00
--
Dec 31, 2025
Two Sigma Investments, LP
604.00
0.03%
+72.00
+13.53%
Dec 31, 2025
MainStreet Advisors
150.00
0.01%
--
--
Dec 31, 2025
Wells Fargo Advisors
125.00
0.01%
-10.00
-7.41%
Dec 31, 2025
Activest Wealth Management LLC
10.00
0%
--
--
Dec 31, 2025
詳现ãèŠã